Lisa C. Richardson, MD, MPH

Lisa C. Richardson, MD, MPH, is DCPC's Associate Director for Science. Her research focuses on access to cancer care, systems of care, health-related quality of life during cancer treatment, health disparities and racial discrimination, and breast cancer treatment patterns of care.

Dr. Richardson oversees the research and scientific content of the Division's programs and products. The Division administers the only organized screening program for low-income uninsured women in the United States, the National Breast and Cervical Cancer and Early Detection Program (NBCCEDP). The Division also administers the National Program of Cancer Registries, which, in collaboration with the National Cancer Institute's Surveillance, Epidemiology and End Results program, covers 99% of the U.S. population for cancer incidence.

Dr. Richardson has held several positions at CDC, including most recently the Team Lead for the Scientific Support and Clinical Translation Team within the Comprehensive Cancer Control Branch. She also served as the NBCCEDP's Medical Director from 1997–1998. Prior to returning to CDC in 2004, she was a faculty member at the University of Florida in Medical Oncology.

Dr. Richardson attended the University of North Carolina at Chapel Hill for her undergraduate studies as well as medical school. She was inducted into the Alpha Omega Alpha medical honor society in 1998. She completed her internal medicine residency and Hematology/Medical Oncology Fellowship at the University of Florida in 1995. She received her MPH in epidemiology from the University of Michigan while she completed the Robert Wood Johnson Clinical Scholars Program from 1995–1997.

Dr. Richardson has authored more than 60 peer-reviewed journal articles. The most recent articles she first-authored include—

• 2011 Testicular cancer: A narrative review of the role of socioeconomic position from risk to survivorship.
• 2011 Vital Signs: colorectal cancer screening, incidence, and mortality—United States, 2002–2010.
• 2011 Use of 2001–2002 Behavioral Risk Factor Surveillance System data to characterize cancer survivors in North Carolina.
• 2010 Obesity and endometrial cancer: challenges for public health action.
• 2010 Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program, 1996–2005.
• 2010 Vital Signs: breast cancer screening among women aged 50–74 years—United States, 2008.
• 2010 Vital Signs: colorectal cancer screening among adults aged 50–75 years—United States, 2008.
• 2008 Ambulatory care for cancer in the United States: results from 2 national surveys comparing visits to physician's offices and hospital outpatient departments.
• 2008 Health-related quality of life in cancer survivors between ages 20 and 64 years: Population-based estimates from the Behavioral Risk Factor Surveillance System.
• 2008 The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer.
• 2006 Can high-grade cervical lesions be managed in a single clinic visit?
• 2006 The roles of teaching hospitals, insurance status, and race/ethnicity in receipt of adjuvant therapy for regional-stage breast cancer in Florida.
• 2005 Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer.
• 2001 Early-stage breast cancer treatment among medically underserved women diagnosed in a national screening program, 1992–1995.

Dr. Richardson is featured in the following podcasts—

• Spotting breast cancer early (1:00) [read tip]
• Prevent Infections During Chemotherapy (2:52)
• Timing Is Everything with Breast Cancer (3:06)
• Caught early (1:00)